Getinge’s heart lung machine HL 40 available for more European hospitals

Report this content

Inspired by perfusionists, Getinge's HL 40 heart-lung machine is designed to increase safety and ensure maximum uptime in cardiac surgery.


Getinge has been at the forefront of providing state of the art systems heart lung machines for decades, and the HL 40 is no exception.

A heart-lung machine permits controlled circulation of oxygenated blood during complex cardiac surgical interventions.

“Surgical perfusion allows no room for error and to get end-user feedback our design team have worked closely with perfusionists from the Leeuwarden Medical Center in the Netherlands and MediClin Herzzentrum Coswig in Germany,” says Dwayne Jones, Product Manager at Getinge. “The cooperation resulted in a highly flexible system with numerous functional enhancements that support best patient outcomes.”

Getinge has achieved an important milestone with the commercial availability of HL 40 in Germany, the Netherlands, Italy, France and Spain, followed by Sweden, Australia, UK and Ireland.

Additional markets are in the planning stages as production is being ramped up for global sales and distribution.

Learn more about HL 40 >>

To find out more about other pending markets, please contact your local Getinge sales representative.


Media contact:

Anna Appelqvist, VP Corporate Communications
Tel.: +46 (0)10-335 5906

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.